News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. – Polyak Lab
Photo from Polyak Lab/Twitter
Sep 11, 2023, 00:27

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. – Polyak Lab

Polyak Lab recently shared on X/Twitter:

“Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for TNBC is out in Molecular Cancer Therapeutics today. Congrats to all the coauthors! And of course a lot more to be explored in the future.”

Our preclinical study evaluating the efficacy of BRD4 inhibitor+Paclitaxel+anti-PD-L1 combination for Triple negative breast cancer is out in Molecular Cancer Therapeutics today. - Polyak Lab

For the article click here.
Source: Polyak Lab/Twitter

anti-PD-L1 BRD4 inhibitor cancer Molecular Cancer Therapeutics OncoDaily Oncology Paclitaxel Polyak Lab TNBC
Special Coverage
Oncolibrary
May 16, 2025, 00:23
Angiogenesis: How New Blood Vessels Shape Health, Healing and Cancer
Blog
May 15, 2025, 22:46
Flavored vapes aren’t harmless: they’re bait - Pink Hearts Cancer Support Foundation
Career
May 15, 2025, 18:27
Celebrating the Lifetime Achievements of Christine Herrison and Andrea Biondi - SIOP Europe
Blog
May 15, 2025, 18:17
Tanja Spanic: Fantastic Sessions at the First day of ESMO Breast 2025
Positive
May 15, 2025, 18:05
Atrium Health Navicent Mobile Mammography Coach Reaches 500th Patient Milestone
Blog
May 15, 2025, 17:55
Saima Saleh: Fabulous Podcast on Breast Cancer Disparities for Black and Brown Women
Blog
May 15, 2025, 17:41
Welcoming Participants to Day 1 of the Cancer Planners Forum in Geneva - UICC
Career
May 15, 2025, 17:33
Alexandre Chan: Faculty Applications are Open at the UC Irvine Department of Clinical Pharmacy Practice
Blog
May 15, 2025, 17:22
SLAOP-ACHOP Cali 2025: Key Topics in Paediatric Oncology and Haematology Shared - SIOP
Blog
May 15, 2025, 17:11
Ending Another Day at SIOP Europe 2025 with Multiple Occasions to Learn and Network
Opinion
May 15, 2025, 17:00
Agenus Bets Big on Botensilimab
Positive
May 15, 2025, 16:42
Alexandre Chan: A Pleasant Surprise from Helen McKinnon and ISOPP